Origin Biologics is relatively new in the US market and draws upon our sister company, Australian Biotechnologies’ extensive 21 year history of producing life enhancing allografts to over 70,000 patients throughout Australia. Origin has partnered with Nevada Donor Network to provide differentiated bone grafting solutions to the surgical marketplace. Our strategy is aligned to recognize the shift in the healthcare marketplace towards “PURE” bone grafting solutions without carriers. In addition, our Dry State technologies maximize the long-term viability of truly valuable donor tissue, thereby supporting our goal of honoring the gift of donation.
We are strategically focused on providing clinically superior products backed by long-term clinical evidence and delivered to our customers in a cost-effective manner.